Ji-zheng Tian

Bone metabolism markers: Indicators of loading dose intravenous ibandronate treatment for bone metastases from breast cancer

Shaohua Zhang, Tao Wang, Zefei Jiang, 2017, Clinical and experimental pharmacology & physiology.

Concomitant Statins and the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Meta-Analysis

Lei Zhang, Hong Wang, Ji-zheng Tian, 2022, International journal of clinical practice.

Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis

Ying Zhang, B. Cao, Guang-Yi Li, 2023, BMC Cancer.

Camrelizumab as a novel third or post-third-line treatment strategy in small cell lung cancer: a retrospective study of 12 patients

Hong Wang, Hong Wang, Xiaoyan Chen, 2023, Frontiers in oncology.

Drug therapy for bone metastasis of malignant tumor: theory, progress, and potential.

Bang-Wei Cao, Kun Shang, Ji-zheng Tian, 2022, Neoplasma.